Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19.
Codina H, Vieitez I, Gutierrez-Valencia A, Skouridou V, Martínez C, Patiño L, Botero-Gallego M, Trujillo-Rodríguez M, Serna-Gallego A, Muñoz-Muela E, Bobillo MM, Pérez A, Cabrera-Alvar JJ, Crespo M, O'Sullivan CK, Ruiz-Mateos E, Poveda E. Codina H, et al. Microorganisms. 2021 Oct 29;9(11):2259. doi: 10.3390/microorganisms9112259. Microorganisms. 2021. PMID: 34835384 Free PMC article.
Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial.
Gutierrez-Valencia A, Benmarzouk-Hidalgo OJ, Rivas-Jeremías I, Espinosa N, Trujillo-Rodríguez M, Fernandez-Magdaleno T, Viciana P, López-Cortés LF. Gutierrez-Valencia A, et al. Clin Infect Dis. 2017 Aug 15;65(4):551-556. doi: 10.1093/cid/cix358. Clin Infect Dis. 2017. PMID: 28449051 Free article. Clinical Trial.
Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
Milanés-Guisado Y, Gutiérrez-Valencia A, Muñoz-Pichardo JM, Rivero A, Trujillo-Rodriguez M, Ruiz-Mateos E, Espinosa N, Roca-Oporto C, Viciana P, López-Cortés LF. Milanés-Guisado Y, et al. J Antimicrob Chemother. 2020 Jan 1;75(1):200-207. doi: 10.1093/jac/dkz421. J Antimicrob Chemother. 2020. PMID: 31617904
Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus.
De Pablo-Bernal RS, Jimenez-Leon MR, Tarancon-Diez L, Gutierrez-Valencia A, Serna-Gallego A, Trujillo-Rodriguez M, Alvarez-Rios AI, Milanes-Guisado Y, Espinosa N, Roca-Oporto C, Viciana P, Lopez-Cortes LF, Ruiz-Mateos E. De Pablo-Bernal RS, et al. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00773-20. doi: 10.1128/AAC.00773-20. Print 2020 Aug 20. Antimicrob Agents Chemother. 2020. PMID: 32571815 Free PMC article.
Mesenchymal stromal cells in human immunodeficiency virus-infected patients with discordant immune response: Early results of a phase I/II clinical trial.
Trujillo-Rodríguez M, Viciana P, Rivas-Jeremías I, Álvarez-Ríos AI, Ruiz-García A, Espinosa-Ibáñez O, Arias-Santiago S, Martínez-Atienza J, Mata R, Fernández-López O, Ruiz-Mateos E, Gutiérrez-Valencia A, López-Cortés LF. Trujillo-Rodríguez M, et al. Stem Cells Transl Med. 2021 Apr;10(4):534-541. doi: 10.1002/sctm.20-0213. Epub 2020 Dec 2. Stem Cells Transl Med. 2021. PMID: 33264515 Free PMC article. Clinical Trial.
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.
Pérez-Gómez A, Vitallé J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Muñoz-Muela E, Jiménez-Leon MLR, Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, Sotomayor C, Roca-Oporto C, Espinosa N, Infante-Domínguez C, Crespo-Rivas JC, Fernández-Villar A, Pérez-González A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 Working Team. Pérez-Gómez A, et al. Cell Mol Immunol. 2021 Sep;18(9):2128-2139. doi: 10.1038/s41423-021-00728-2. Epub 2021 Jul 21. Cell Mol Immunol. 2021. PMID: 34290398 Free PMC article.
Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial.
Trujillo-Rodríguez M, Muñoz-Muela E, Serna-Gallego A, Milanés-Guisado Y, Praena-Fernández JM, Álvarez-Ríos AI, Herrera-Hidalgo L, Domínguez M, Lozano C, Romero-Vazquez G, Roca C, Espinosa N, Gutiérrez-Valencia A, López-Cortés LF. Trujillo-Rodríguez M, et al. Clin Microbiol Infect. 2022 Aug;28(8):1151.e9-1151.e16. doi: 10.1016/j.cmi.2022.02.041. Epub 2022 Mar 11. Clin Microbiol Infect. 2022. PMID: 35289296 Free article. Clinical Trial.
42 results